Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Zosano Pharma Corporation (ZSAN)
Newly released Crypto mining rig for Zosano Pharma Corporation coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Zosano Pharma Corporation (ZSAN) Reports Q2 Loss, Misses Revenue Estimates
4 days ago | Zacks Investment Research
Zosano Pharma Reports Second Quarter 2021 Financial Results
4 days ago | GlobeNewsWire
Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Treatment of Migraine
3 weeks ago | GlobeNewsWire
ZSAN Stock: Why Zosano Pharma Is Racing Higher Today
2 months ago | InvestorPlace
Zosano Stock Surges After New Study Shows Qtrypta's Potential As Long-Term Treatment Option For Migraine
2 months ago | Benzinga
ZSAN Stock Price: Over 30% Increase Pre-Market Explanation
2 months ago | Pulse2
Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acute Migraine in The Journal of Headache and Pain
2 months ago | GlobeNewsWire
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors
2 months ago | GlobeNewsWire
Zosano Pharma Reports First Quarter 2021 Financial Results
3 months ago | GlobeNewsWire
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
5 months ago | GlobeNewsWire

About:

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

45

Address:

Zosano Pharma Corporation 34790 Ardentech Court Fremont CA 94555 United States

Website:

http://www.zosanopharma.com

Phone:

510-745-1200

Leave a comment

Your email address will not be published. Required fields are marked *